Michael Neise

Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma

Mathias Rummel, S. Al-Batran, Soo-Z. Kim et al. · Journal of Clinical Oncology · 2005 · 440 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker et al. · Leukemia · 2020 · 92 citations · Full text

Life Sciences, Hematology, Oncology +16

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 62 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

Jens Huober, W. Fett, Arnd Nusch et al. · BMC Cancer · 2010 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma

J. T. Hartmann, Hans‐Georg Kopp, Viktor Gruenwald et al. · European Journal of Cancer · 2019 · 38 citations

Medicine, Oncology, Pharmacology +15